Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient
Víctor Manuel Anguiano-Álvarez1, José Antonio Maza-Larrea2, Francisco Javier Rosado-Hernández2, Gustavo Rojas-Velasco3, Raúl Izaguirre-Ávila1
1Department of hematology, 2Department of Pharmacovigilance, 3Department of Intensive Care Unit, National Institute of Cardiology Ignacio Chávez, Mexico City, Mexico
Correspondence to: Víctor Manuel Anguiano Álvarez
Instituto Nacional de Cardiología Ignacio Chávez, Calle Juan Badiano 1, Col. Sección XVI, Tlalpan, 14080 Ciudad de México, Mexico
E-mail: vanguiano@comunidad.unam.mx
Published online: August 12, 2021.
© The Korean Journal of Hematology. All rights reserved.



e-submission

This Article

Current Issue

ba_link01

SCImago Journal & Country Rank

Indexed/Covered by

Today : 68  /
Total : 335,500